Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
BioCentury This Week
00:00
Are You Considering a Synthetic Royalty Deal?
In the sepa market, the closer you are to having a marketed product facebe, the more optionality or opportunities you have. In one of those that seems like there's getting a lot of interest of late are around royalty deals. These aren't just selling existing royalties, but creating synthetic royalties. And so i think that' that's an interesting route for companies to take - it doesn't create this huge tential deat albatross kind of round the company's neck which could hurt them in future.
Transcript
Play full episode
